Actively Recruiting
Association Between Venous Excess Ultrasound, Lung Ultrasound Score, and Acute Kidney Injury and Death in ICU Patients
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-09-05
136
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the relationship between the venous excess ultrasound grading system (VExUS) and important health outcomes in patients admitted to the intensive care unit (ICU). The study focuses on how VExUS relates to acute kidney injury, mortality, and length of hospital stay. Additionally, the connection between VExUS and lung ultrasound scores will be explored as a secondary analysis to better understand fluid overload risks in ICU patients. The study is observational and involves monitoring patients admitted to the ICU who are 18 years or older and expected to stay more than 24 hours. There are no experimental treatments in this study; instead, ultrasound assessments including VExUS and lung ultrasound scores will be performed to gather data. These ultrasound techniques are used to evaluate how the body handles fluids and to identify patients at risk of fluid overload. Participants will undergo ultrasound assessments and their health outcomes will be tracked for up to 30 days after ICU admission. Researchers will collect data on acute kidney injury rates, mortality, and major adverse kidney events within this period. No experimental interventions are given, and the study aims to observe natural outcomes while using ultrasound tools to improve fluid management understanding in the ICU setting.
CONDITIONS
Brief Title
Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to the ICU who are 18 years or older
- Expected to stay in the ICU for more than 24 hours
You will not qualify if you...
- Any obstruction between the right atrium and structures assessed by VExUS
- History of major cardiac shunts such as atrial septum defect
- History of tricuspid regurgitation
- History of dialysis treatment
- History of portal hypertension
- History of pulmonary hypertension
- History of interstitial lung disease
- Recipients of kidney or liver transplant
- Patients for whom ultrasound assessment is not feasible, such as those with a BMI over 40
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 30 days
Participants undergo venous excess ultrasound and lung ultrasound scoring to assess their condition.
Ultrasound assessments performed during ICU stay
Duration - Up to 30 days
Participants are monitored for acute kidney injury, mortality, and other outcomes during and up to 30 days following ICU admission.
Continuous clinical monitoring during ICU stay and follow-up assessments as per routine care
Trial Site Locations
Total: 1 location
1
Amsterdam UMC
Amsterdam, North Holland, Netherlands, 1081HV
Actively Recruiting
Research Team
P
Pieter R Tuinman, PhD
P
P Klompmaker, MSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here